Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus' ability to invade human cells. SARS-CoV-2 is the virus that spreads COVID-19.
Variations in the expression of these genes can causes differences in everything from eye color to blood type to cancer and disease risks. Testing has increased tenfold over the past decade for ...
Certis Oncology Solutions, led by Peter Ellman, President and CEO, is a life science technology company dedicated to realizing the promise of precision oncology. The company’s product is Oncology ...